Fate Therapeutics Inc (NASDAQ:FATE)

5.14
Delayed Data
As of 4:00pm ET
 -0.28 / -5.17%
Today’s Change
4.02
Today|||52-Week Range
43.12
-49.06%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close5.42
Today’s open5.42
Day’s range5.13 - 5.47
Volume164,418
Average volume (3 months)3,317,411
Market cap$548.7M
Data as of 4:00pm ET, 03/22/2023

Growth & Valuation

Earnings growth (last year)-29.95%
Earnings growth (this year)+27.11%
Earnings growth (next 5 years)+30.90%
Revenue growth (last year)+72.44%
P/E ratioNM
Price/Sales10.15
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.13-7.98%
NVAXNovavax Inc-0.24-3.99%
MORMorphoSys AG-0.11-2.76%
ALECAlector Inc-0.33-5.37%
Data as of 4:00pm ET, 03/22/2023

Financials

Next reporting dateMay 3, 2023
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$96.3M
Annual profit (last year)-$281.7M
Net profit margin-292.55%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts